EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Synthesis, Characterization, and enhancement of efficacy of losartan with minimal excipients

Sameer Gul

Pharmaceutical Communications · 2024

DOI: 10.55627/pharma.003.002.01086 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutical Communications, 2024. Verfasst von Sameer Gul. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Stroke is commonly caused by blood-circulation blockage due to a blood clot (Feske 2021) or rupture of a blood vessel (Arturo Montaño 2021, Eric E. Smith 2005); furthermore, they are among major reasons for incapacity and demise (Mendis 2013, Charles Ellis 2010). A number of cardiovascular conditions can result in heart failure, which further exacerbates cardiovascular disease burdens. Besides peripheral artery disease, arrhythmias, and other cardiovascular diseases contribute to this global health problem. Not only do cardiovascular diseases manifest in various forms, but they are also difficult to treat due to their sudden onset and chronic nature. In order to cure and cope with the difficulties of cardiovascular diseases engineers have innovated many biomaterials that are used as regenerative therapy(Yunbing Wang 2022). Hence an elaborate study is done in this review article that gives information and detail about the use of different biomaterials in cardiovascular disorders.

Zitieren

APA

Gul, S. (2024). Synthesis, Characterization, and enhancement of efficacy of losartan with minimal excipients. Pharmaceutical Communications. https://doi.org/10.55627/pharma.003.002.01086

Vancouver

Gul S. Synthesis, Characterization, and enhancement of efficacy of losartan with minimal excipients. Pharmaceutical Communications. 2024. doi:10.55627/pharma.003.002.01086

BibTeX
@article{Gul2024,
  author = {Gul, Sameer},
  title = {Synthesis, Characterization, and enhancement of efficacy of losartan with minimal excipients},
  journal = {Pharmaceutical Communications},
  year = {2024},
  doi = {10.55627/pharma.003.002.01086}
}
Kostenlos starten →